HR Execs on the Move


 
Gravie has been at the forefront of driving change and improving the healthcare industry by creating innovative employer-sponsored health benefit solutions that put consumers first. Comfort™, Gravie`s flagship product, is the nation`s first-of-its-kind health plan that provides zero-deductible, zero-copay, and 100% coverage on most common healthcare services, at a cost comparable to most traditional group health plans.
  • Number of Employees: 100-250
  • Annual Revenue: $50-100 Million
  • www.gravie.com
  • 10 South 5th Street Sute 650
    Minneapolis, MN USA 55402
  • Phone: 612.355.1590

Executives

Name Title Contact Details
Rebecca Nash
SVP, Chief Human Resources Officer Profile
Kevin Kickhaefer
president and chief growth officer Profile
Amy Spartz
Chief People Officer Profile
Nicole Lovaas
VP of Product, Analytics Profile
Marek Ciolko
Co-Founder and Chief Executive Officer Profile

Similar Companies

ION Medical

ION Medical is a Mission Viejo, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cerebros Medical Systems

Cerebros Medical Systems is a Scranton, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Travel Nurses

Travel Nurses, Inc. is a healthcare staffing agency that provides travel nurse contracts and staffing services for nurses and allied professionals nationwide.

Prairie Senior Cottages

Prairie Senior Cottages is a Willmar, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PharmaBlock Sciences

PharmaBlock Sciences (Nanjing), Inc. is a leading innovative chemistry products and services provider throughout the pharmaceutical R&D process. Its core businesses include: a catalog of specially designed scaffolds and building blocks; custom synthesis; process development; manufacturing of key intermediates and RSMs; and FTE services. The company was listed on Shenzhen Exchange Stock in China on November 10, 2017. PharmaBlock has rapidly gained recognition for its outstanding capability in the design, synthesis, and supply of lab scale building blocks. Building on that success, the company acquired Shandong Diai Biotechnology Co., Ltd. as its pilot plant and manufacturing site in 2016, and is providing scale-up synthesis and manufacturing of key intermediates/RSMs. PharmaBlock is now committed to a more comprehensive and long-term service to valued customers.